Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 85251-85300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06331988
Microbiome, Immune-system and Tumor Interaction in Colorectal Cancer
N/ARecruiting
320 participants
Started: Jul 21, 2022 · Completed: Jul 31, 2029
1 condition1 sponsor1 location
NCT05754645
The Microbiome in (Non-) Obese Pregnancy and Pregnancy Outcomes
N/ARecruiting
110 participants
Started: Jul 21, 2022 · Completed: Aug 21, 2026
3 conditions1 sponsor1 location
NCT05313945
Evaluation Patient Satisfaction After Passive Bladder Catheter Removal Compared to Active Removal
NARecruiting
160 participants
Started: Jul 21, 2022 · Completed: Mar 21, 2026
1 condition1 sponsor2 locations
NCT05458297
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
PHASE2Recruiting
223 participants
Started: Jul 21, 2022 · Completed: May 17, 2029
4 conditions1 sponsor109 locations
NCT05208307
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
PHASE2Recruiting
34 participants
Started: Jul 21, 2022 · Completed: Oct 21, 2027
1 condition3 sponsors1 location
NCT05590247
Role of Intermittent Fasting in Psoriasis and Psoriatic Arthritis
NAActive, not recruiting
60 participants
Started: Jul 21, 2022 · Completed: Sep 1, 2026
2 conditions2 sponsors1 location
NCT05291156
CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
PHASE2Recruiting
173 participants
Started: Jul 21, 2022 · Completed: Jul 1, 2025
1 condition1 sponsor24 locations
NCT05332925
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
N/ARecruiting
25 participants
Started: Jul 21, 2022 · Completed: Feb 28, 2027
3 conditions2 sponsors2 locations
NCT04165486
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)
PHASE1Recruiting
40 participants
Started: Jul 21, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor14 locations
NCT06179680
White Matter Hyperintensities in Amnestic Mild Cognitive Impairment or Alzheimer's Disease
N/ARecruiting
142 participants
Started: Jul 21, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05396170
Effect of Phlebotomy on Heartrate in Polycythemia Patients
N/ARecruiting
10 participants
Started: Jul 21, 2022 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05376553
Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
PHASE1Enrolling by invitation
24 participants
Started: Jul 20, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05638724
Munich Long COVID Registry for Children, Adolescents, and Adults
N/ARecruiting
1,000 participants
Started: Jul 20, 2022 · Completed: Jul 20, 2027
1 condition11 sponsors1 location
NCT06190821
Hydrodissection of the Hepatoduodenal Ligament
N/ARecruiting
13 participants
Started: Jul 20, 2022 · Completed: Feb 20, 2025
1 condition1 sponsor1 location
NCT05269680
STAR-LIFE: a Post-market Registry on MINIject
N/ARecruiting
750 participants
Started: Jul 20, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05301413
Social Determinants and a Diabetes Prevention Program Tailored for African Americans
PHASE2Recruiting
360 participants
Started: Jul 20, 2022 · Completed: Feb 28, 2026
2 conditions5 sponsors2 locations
NCT05198557
A Study of MT-0551 in Patients With Systemic Sclerosis
PHASE3Active, not recruiting
80 participants
Started: Jul 20, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor4 locations
NCT05361174
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
PHASE1/PHASE2Recruiting
53 participants
Started: Jul 20, 2022 · Completed: Jun 30, 2027
4 conditions1 sponsor10 locations
NCT05675891
Oral Feeding Ability of Preterm Infants With Breastfeeding Support System
NARecruiting
60 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2023
2 conditions1 sponsor1 location
NCT05379101
Intracardiac Flow Assessment in Cardiac Amyloidosis
N/ARecruiting
100 participants
Started: Jul 20, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05451784
Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS
PHASE1/PHASE2Recruiting
20 participants
Started: Jul 20, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors4 locations
NCT05282108
Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia
N/ARecruiting
240 participants
Started: Jul 20, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor4 locations
NCT05451953
Providing Oxygen During Intubation in the NICU Trial
NARecruiting
110 participants
Started: Jul 20, 2022 · Completed: Feb 28, 2027
2 conditions3 sponsors1 location
NCT05482763
Mycosis Culture Collection From Dermatological Isolated
N/AActive, not recruiting
200 participants
Started: Jul 20, 2022 · Completed: Dec 25, 2025
3 conditions1 sponsor1 location
NCT05051397
CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke
PHASE2Recruiting
50 participants
Started: Jul 20, 2022 · Completed: Oct 19, 2026
5 conditions1 sponsor1 location
NCT05785143
Timing of Damage Control Orthopedic Surgery
N/AActive, not recruiting
100 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT05260047
Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population
NARecruiting
525 participants
Started: Jul 20, 2022 · Completed: Oct 1, 2026
4 conditions2 sponsors8 locations
NCT05388773
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
PHASE2Recruiting
150 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT04473794
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
N/ARecruiting
5,000 participants
Started: Jul 20, 2022 · Completed: Aug 1, 2036
2 conditions2 sponsors1 location
NCT05135975
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
PHASE2Recruiting
86 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2029
2 conditions2 sponsors6 locations
NCT06386705
TSN084 Treating Patients With Advanced Malignant Tumors
PHASE1Recruiting
114 participants
Started: Jul 20, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations
NCT04845542
Promoting Resilience in Stroke Survivor-carepartner Dyads (ReStoreD)
NARecruiting
400 participants
Started: Jul 20, 2022 · Completed: Aug 31, 2027
4 conditions1 sponsor1 location
NCT06594315
Assessing Brain Metabolism Using MRS With Deuterated Glucose
N/AActive, not recruiting
80 participants
Started: Jul 20, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05150210
SP Thoracic IDE Study
NAActive, not recruiting
32 participants
Started: Jul 20, 2022 · Completed: Jul 31, 2028
4 conditions1 sponsor6 locations
NCT06029517
A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
NAActive, not recruiting
48 participants
Started: Jul 20, 2022 · Completed: Sep 15, 2026
4 conditions2 sponsors1 location
NCT05408377
Effectiveness of Acupuncture for Cyclical Mastalgia (CM)
NARecruiting
108 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT05416411
Preoperative RESpiratory Training and MOBilization to Prevent Postoperative Pulmonary Complications in Patients Undergoing Thoracic Surgery
NARecruiting
436 participants
Started: Jul 20, 2022 · Completed: Jul 10, 2024
2 conditions1 sponsor3 locations
NCT05148364
Pain Resilience and Spiritual Health in Low Back Pain
N/ARecruiting
15 participants
Started: Jul 20, 2022 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT05485649
Clinical Outcomes of Pregnant Individuals With Epilepsy - Prospective Study
N/ARecruiting
80 participants
Started: Jul 20, 2022 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT05382299
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
PHASE3Active, not recruiting
623 participants
Started: Jul 20, 2022 · Completed: Jul 31, 2028
2 conditions1 sponsor363 locations
NCT07210879
Early Predictors for Neurological Outcome After Traumatic Spinal Cord Injury
N/AActive, not recruiting
800 participants
Started: Jul 20, 2022 · Completed: Aug 30, 2026
1 condition3 sponsors1 location
NCT05265273
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
PHASE2/PHASE3Recruiting
12 participants
Started: Jul 20, 2022 · Completed: Jun 26, 2026
1 condition1 sponsor19 locations
NCT05450978
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
N/ARecruiting
60 participants
Started: Jul 20, 2022 · Completed: Apr 1, 2028
2 conditions2 sponsors1 location
NCT05196087
Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
N/ARecruiting
500 participants
Started: Jul 20, 2022 · Completed: Jun 30, 2027
3 conditions2 sponsors1 location
NCT05626829
Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma
PHASE2Recruiting
18 participants
Started: Jul 20, 2022 · Completed: Nov 30, 2024
2 conditions1 sponsor1 location
NCT06197880
Airway Morphology After En-masse Retraction in Bimaxillary Protrusion Patients
NAActive, not recruiting
20 participants
Started: Jul 20, 2022 · Completed: Feb 1, 2024
1 condition1 sponsor1 location
NCT05334329
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors
PHASE1Active, not recruiting
6 participants
Started: Jul 20, 2022 · Completed: Jun 14, 2026
11 conditions2 sponsors1 location
NCT05197322
NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer
PHASE2Recruiting
78 participants
Started: Jul 20, 2022 · Completed: Dec 31, 2028
1 condition7 sponsors5 locations
NCT05413850
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
PHASE1/PHASE2Recruiting
82 participants
Started: Jul 20, 2022 · Completed: Mar 31, 2028
6 conditions2 sponsors5 locations
NCT05474079
Exercise Training & Statins for Cardiovascular Health
NARecruiting
80 participants
Started: Jul 20, 2022 · Completed: Jan 1, 2026
2 conditions2 sponsors1 location